Company / Current Liabilities per Share
Arcturus Therapeutics Holdings Inc. Current Liabilities per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.35
FY2025
5-year range
$1.35 / $4.82
FY2021-FY2025
Trend
-44.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has declined for 3 consecutive years, from $4.82 in FY2022 to $1.35 in FY2025.
Based on SEC 10-K filings.
1.35 in FY2025 with a 5-year CAGR of -16.3%.
Improved from $3.09 to $1.35 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -34.6%
- 5-Year CAGR
- -16.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- Arcturus Therapeutics Holdings Inc.'s current liabilities per share has declined for 3 consecutive years.
- In FY2025, current liabilities per share decreased 44.8% year-over-year.
- Peak current liabilities per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.35 | -44.8% |
| FY2024 | $2.44 | -20.9% |
| FY2023 | $3.09 | -35.9% |
| FY2022 | $4.82 | +26.7% |
| FY2021 | $3.80 | +16.2% |
| FY2020 | $3.27 | +64.4% |
| FY2019 | $1.99 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026